Abstract:Determining the phenotypic effects of single nucleotide variants is critical for understanding the genome and interpreting clinical sequencing results. Base editors, including diversifying base editors that create C>N mutations, are potent tools for installing point mutations in mammalian genomes and studying their effect on cellular function. Numerous base editor options are available for such studies, but little information exists on how the composition of the editor (deaminase, recruitment method, and fusion architecture) affects editing. To address this knowledge gap, the effect of various design features, such as deaminase recruitment and delivery method (electroporation or lentiviral transduction), on editing was assessed across ~200 synthetic target sites. The direct fusion of a hyperactive variant of activation-induced cytidine deaminase to the N-terminus of dCas9 (DivA-BE) produced the highest editing efficiency, ~4-fold better than the previous CRISPR-X method. Additionally, DivA-BE mutagenized the DNA strand that anneals to the targeting sgRNA to create G>N mutations, which were absent when the deaminase was fused to the C-terminus of dCas9. The DivA-BE editors efficiently diversified their target sites, an ideal characteristic for discovering functional variants. These and other findings provide a comprehensive analysis of how design features influence the activity of several popular base editors.

The Development and Application of a Base Editor in Biomedicine

Development and application of CRISPR/Cas9 technologies in genomic editing.

Development and Application of Base Editors.

Breaking genetic shackles: The advance of base editing in genetic disorder treatment

Development and application of base editors in bacterial genome editing

A Review of Application of Base Editing for the Treatment of Inner Ear Disorders

Progression and application of CRISPR-Cas genomic editors

[Advances in base editing systems]

CRISPR-Mediated Base Editing: Promises and Challenges for a Viable Oncotherapy Strategy.

CRISPR-Mediated Base Editing: from Precise Point Mutation to Genome-Wide Engineering in Nonmodel Microbes

Base Editing and its Applications in Gene Therapy

Advancing CRISPR base editing technology through innovative strategies and ideas

Highly Efficient Base Editing in Rabbit by Using Near-Pamless Engineered CRISPR/Cas9 Variants

Disease modeling by efficient genome editing using a near PAM-less base editor in vivo

CRISPR-Cas9 DNA Base-Editing and Prime-Editing

Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope

Base Editors-Mediated Gene Therapy in Hematopoietic Stem Cells for Hematologic Diseases

Translational potential of base-editing tools for gene therapy of monogenic diseases

Powerful Microbial Base-Editing Toolbox: From Optimization Strategies to Versatile Applications

Towards optimizing diversifying base editors for high-throughput studies of single-nucleotide variants

CRISPR/Cas base-editing systems and their potential applications and prospects